Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual patient number (62) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.